TYP tryptamine therapeutics limited

Codiak ($800mil market capitalisation), page-158

  1. 1,216 Posts.
    lightbulb Created with Sketch. 1375
    Does anyone on this forum even understand what exosomes are? You do realise that no two exosomes are alike? How do you expect the FDA to ever approve such a heterogenous product. And how do you expect EX1 to determine the MOA? Its no good just isolating exosomes and seeing if they heal wounds. The real value is when EX1 can engineer exosomes, which is at least 10-15 years away to develop a product that can even be tested.

    FYI you lot are just paying for scientific research.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
3.2¢
Change
0.000(0.00%)
Mkt cap ! $44.44M
Open High Low Value Volume
3.3¢ 3.3¢ 3.2¢ $39.58K 1.234M

Buyers (Bids)

No. Vol. Price($)
5 966515 3.1¢
 

Sellers (Offers)

Price($) Vol. No.
3.3¢ 67037 4
View Market Depth
Last trade - 12.40pm 22/07/2025 (20 minute delay) ?
TYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.